4//SEC Filing
McKelligon Brian 4
Accession 0001062993-24-019518
CIK 0001711933other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:18 PM ET
Size
5.2 KB
Accession
0001062993-24-019518
Insider Transaction Report
Form 4
McKelligon Brian
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-11-19+218,750→ 443,483 total
Footnotes (2)
- [F1]The restricted stock units shall vest as to 50% on the first anniversary of the first day of the month subsequent to the date of grant (the "First Vesting Date") with the remainder vesting as follows: 25% on the date that is three months following the First Vesting Date; 25% on the date that is six months following the First Vesting Date; 25% on the date that is nine months following the First Vesting Date; and 25% on the date that is twelve months following the First Vesting Date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.
Issuer
Akoya Biosciences, Inc.
CIK 0001711933
Entity typeother
Related Parties
1- filerCIK 0001857447
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 5:18 PM ET
- Size
- 5.2 KB